A Japanese research team has developed artificial intelligence models that can help deliver personalized infertility treatments by predicting the number and quality of eggs that a woman has. The AI models can accurately predict a patient's ovarian function by using answers to simple questions -- such as age and menstrual cycle -- and a small sampling of blood, according to the group study led by University of Tokyo researcher Miyuki Harada. The group collected data from 442 patients who were undergoing infertility treatment between June 2021 and January 2023 in Japan. Using their medical records and residual serum, the group created multiple AI prediction models.

With machine learning, Mayo Clinic researchers found it is possible to predict how patterns of changes in pregnant patients who are in labor can help identify whether a vaginal delivery will occur with good outcomes for mom and baby. WHY IT MATTERS The ability to change the shape of and open the birth canal to make way for a baby to be born varies from patient to patient. When obstetricians analyze contractions, as well as fetal heartbeats, they assess the progress of labor and make recommendations on levels of care for the medically-risky delivery process of birth. Mayo Clinic researchers say these new models can predict a composite of medical outcomes and the probability of poor labor outcomes – cesarean delivery in active labor, postpartum hemorrhage, intra-amniotic infection, shoulder dystocia, neonatal morbidity and mortality – based on what machine learning can do with dilation data. Use of the models could result in more individualized clinical decisions using the baseline characteristics of each patient, and they could also be a tool to help remote physicians and midwives transfer rural or remote patients to the appropriate level of care, said Dr. Abimbola Famuyide, a Mayo Clinic OB-GYN and senior author of the study in a prepared statement.

Nucleome Therapeutics is an exciting new venture that just spun out from a decade of research at Oxford University with the aim to unlock the non-coding part of the genome to help deliver life changing treatments. Our pioneering genomics platform uses the 3D structure of the genome and AI powered computational genomics to decode and mine the regulatory "dark matter" of the human genome to help deliver the next generation of genetically guided therapeutics. Our vision and commitment is shared by Oxford Sciences Innovation who backed us with a £5.2 million seed investment. We are building a passionate, creative and dedicated multi-disciplinary team of scientists with expertise in gene regulation, genomics, machine learning, data analysis and software development. Our mission is to decode and mine the regulatory "dark matter" of the human genome to transform drug target discovery and help deliver the next generation of genetically guided therapeutics.

When my son was a toddler, he went to his pediatrician for a routine CAT scan. He'd be awake and finished in a jiffy. He lay there on the clinic table, unresponsive, his vitals slowly falling. The clinic had no ability to diagnose his condition. Five minutes later, he was in the back of an ambulance.

The artificial intelligence (AI) industry is growing at a rapid pace, with an expected value approaching $60 billion in 2025. Additionally, Gartner predicts that AI will be in almost every software product by 2020. The general public is already familiar with AI in the forms of personal assistants like Siri and Alexa. People reading this article will be aware that online customer service typically begins with chatbots. Most will have used navigation apps and be aware of how our future will include self-driving cars.

Around October 2015, Google announced it would be using artificial intelligence to help deliver its search results. This machine-learning AI system is called RankBrain. Since RankBrain uses machine-learning AI, it learns by itself, consuming web pages and search queries by the second with the intent of delivering the best and most relevant results to users. You need to understand that this is an addition to Google's algorithm and not an algorithm update such as Hummingbird, Penguin, etc. In fact, it is reported that RankBrain is now Google's third most important signal contributing to search queries and results.